This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Co-Diagnostics stock | $10.96

Own Co-Diagnostics stock in just a few minutes.

Fact checked
Co-Diagnostics logo

Co-Diagnostics, Inc (CODX) is a leading diagnostics & research business based in the US. It opened the day at USD$10.9 after a previous close of USD$10.97. During the day the price has varied from a low of USD$10.65 to a high of USD$11.03. The latest price was USD$10.96 (25 minute delay). Co-Diagnostics is listed on the NASDAQ and employs 39 staff. All prices are listed in US Dollars.

About our promoted products: Our 'promoted' products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you. Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment

How to buy shares in Co-Diagnostics from New Zealand

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Co-Diagnostics Find the stock by name or ticker symbol: CODX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Co-Diagnostics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$12.12, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Co-Diagnostics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Co-Diagnostics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

US share trading platforms

Data indicated here is updated regularly
Name Product Min. monthly fee Currency conversion fee Available markets
Stake
$0
1% ($2 min)
NASDAQ, NYSE, BATS, Chicago Stock Exchange, and more
Sign up through Finder and use referral code "FINDERNZ" for a free stock. Trade more than 3,800 US-listed stocks and ETFs through Stake with $0 fees on trades.
Hatch
$0
0.5%
NASDAQ, NYSE
Invest in more than 3,500 US companies and exchange-traded funds (ETFs). No minimum investment or monthly fees.
Sharesies
$0
0.4%
NASDAQ, NYSE, NZX, CBOE
loading

Compare up to 4 providers

Invest in a shares CFD

Important: By investing in a share CFD, you are speculating on the price movement of that share and do not have ownership of the underlying asset. CFDs are complicated financial products are are more suited to experienced trader. Learn more about CFD trading
Data indicated here is updated regularly
Name Product Minimum Opening Deposit Minimum Opening Deposit Commission Available Markets Platforms
Plus500 CFD
NZ 100
100
No commission
Global shares, indices, options, ETFs
Plus500 Web Trader
CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment.Trade CFDs on shares, forex, indices, commodities and more.
IG Markets CFDs
AUD 0
0
0.08% with $7 minimum
Indices, Options, FX, Shares, Commodities, Cryptocurrency, ETPs
MetaTrader 4
ProReal Time
CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment. Trade from over 15,000 markets with a leading service for CFD trading and forex.
BlackBull Markets CFD
USD 200
200
No commission
Indices, FX, Commodities, Precious Metals
MetaTrader 4, MetaTrader 5
CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment. Trade CFDs on shares, forex, indices, commodities, precious metals and more.
loading

Compare up to 4 providers

Co-Diagnostics share price

Use our graph to track the performance of CODX stocks over time.

Co-Diagnostics shares at a glance

Information last updated 2020-12-03.
Open USD$10.9
High USD$11.03
Low USD$10.65
Close USD$10.96
Previous close USD$10.97
Change USD$-0.01
Change % -0.091%
Volume 919,744
Information last updated 2020-12-02.
52-week range USD$0.88 - USD$29.99
50-day moving average USD$12.9739
200-day moving average USD$15.951
Wall St. target price USD$30.67
PE ratio 10.0063
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.122

Co-Diagnostics price performance over time

Historical closes compared with the last close of $10.96

1 week (2020-11-27) -7.82%
1 month (2020-11-04) -22.93%
3 months (2020-09-04) 33.01%
6 months (2020-06-04) -35.26%
1 year (2019-12-04) 974.51%
2 years (2018-12-04) 390.60%
3 years (2017-12-04) 121.41%
5 years (2015-11-30) N/A

Is Co-Diagnostics under- or over-valued?

Valuing Co-Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Co-Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Co-Diagnostics's P/E ratio

Co-Diagnostics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Co-Diagnostics shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Co-Diagnostics's EBITDA

Co-Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$24.1 million.

The EBITDA is a measure of a Co-Diagnostics's overall financial performance and is widely used to measure a its profitability.

Shorting Co-Diagnostics shares

There are currently 6.9 million Co-Diagnostics shares held short by investors – that's known as Co-Diagnostics's "short interest". This figure is 7.5% up from 6.5 million last month.

There are a few different ways that this level of interest in shorting Co-Diagnostics shares can be evaluated.

Co-Diagnostics's "short interest ratio" (SIR)

Co-Diagnostics's "short interest ratio" (SIR) is the quantity of Co-Diagnostics shares currently shorted divided by the average quantity of Co-Diagnostics shares traded daily (recently around 1.7 million). Co-Diagnostics's SIR currently stands at 3.98. In other words for every 100,000 Co-Diagnostics shares traded daily on the market, roughly 3980 shares are currently held short.

However Co-Diagnostics's short interest can also be evaluated against the total number of Co-Diagnostics shares, or, against the total number of tradable Co-Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Co-Diagnostics's short interest could be expressed as 0.25% of the outstanding shares (for every 100,000 Co-Diagnostics shares in existence, roughly 250 shares are currently held short) or 0.2457% of the tradable shares (for every 100,000 tradable Co-Diagnostics shares, roughly 246 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Co-Diagnostics.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site